C. Lamberth et al. / Bioorg. Med. Chem. 20 (2012) 2803–2810
2809
pressure. The remainder was taken up with ethyl acetate. The
4.1.9. 3,6-Dichloro-4-(4-chloro-phenyl)-5-(2,4,6-trifluoro-
phenyl)-pyridazine (17)
mixture of 4-(4-chloro-phenyl)-5-(2,4,6-trifluoro-phenyl)-
resulting solution was washed with water and brine, dried over so-
dium sulfate and evaporated. The residue was purified by chroma-
tography on silica gel, using ethyl acetate/cyclohexane 1:6 as
eluent, delivering 3-chloro-5-(5-chloro-thiophen-2-yl)-6-methyl-
4-(2,4,6-trifluoro-phenyl)-pyridazine (10, 880 mg, 2.3 mmol,
94%). Mp 102–103 °C. 1H NMR (CDCl3): d = 2.70 (s, 3H), 6.69–6.75
(m, 3H), 6.82 (d, 1H). MS (ESI): m/z = 375 (M), 377 (M+2).
A
1,2-dihydropyridazine-3,6-dione (16, 45 g, 0.13 mol) and 230 ml
of phosphorus oxychloride was heated to 120 °C for 2 h. The
reaction mixture was cooled and evaporated under reduced
pressure. The remainder was poured on water and extracted with
ethyl acetate. The organic layer was washed with brine, dried
over sodium sulfate and evaporated. The residue was purified by
chromatography on silica gel, using ethyl acetate/heptane 1:8
as eluent, delivering 3,6-dichloro-4-(4-chloro-phenyl)-5-(2,4,6-tri-
fluoro-phenyl)-pyridazine (17, 29 g, 75 mmol, 57%) as beige
crystals. 1H NMR (CDCl3): d = 6.59 (t, 2H), 7.01 (d, 2H), 7.26 (d, 2H).
MS (ESI): m/z = 390 (M), 393 (M+3).
4.1.6. 4-Chloro-phenylglyoxylic acid (14)
Methyl oxalyl chloride (265 g, 2.16 mol) was slowly added to a
suspension of aluminium chloride (200 g, 1.5 mol) in 750 ml of
chloroform at 0 °C. The reaction mixture was stirred for 1 h at
0 °C, then chlorobenzene (245 g, 2.19 mol) was slowly added at this
temperature. The resulting mixture was stirred for 16 h at room
temperature, then poured on water and diluted with dichlorometh-
ane. The phases were separated, the organic layer was washed with
water, dried over sodium sulfate and evaporated. The remainder
was purified by chromatography on silica gel, using ethyl acetate/
heptane 1:9 as eluent, delivering methyl 4-chloro-phenylglyoxy-
late (99 g, 0.5 mol). This intermediate was dissolved in 800 ml of
dioxane and 800 ml of 1 N sodium hydroxide were added. The mix-
ture was stirred for 2 h at room temperature, then acidified to pH 1
with 2 N hydrochloric acid and extracted with ethyl acetate. The or-
ganic layer was washed with brine, dried over sodium sulfate and
evaporated to deliver 4-chloro-phenylglyoxylic acid (14, 86 g,
0.47 mol 21%). 1H NMR (CDCl3): d = 7.53 (d, 2H), 8.10 (br s, 1H),
8.32 (d, 2H). MS (ESI): m/z = 186 (M+1), 165 (M–OH).
4.1.10. 3-Chloro-5-(4-chloro-phenyl)-6-methoxy-4-(2,4,6-
trifluoro-phenyl)-pyridazine (18)
0.25 g of a 30% solution of sodium methoxide in methanol was
added to a solution of 3,6-dichloro-4-(4-chloro-phenyl)-5-(2,4,6-
trifluoro-phenyl)-pyridazine (17, 0.48 g, 1.2 mmol) in 5 ml of
methanol. The reaction mixture was heated to reflux for 2 h, then
cooled, diluted with water and extracted with ethyl acetate. The
organic layer was washed with brine, dried over sodium sulfate
and evaporated. The remainder was purified by chromatography
on silica gel, using ethyl acetate/heptane 1:9 as eluent, delivering
3-chloro-5-(4-chloro-phenyl)-6-methoxy-4-(2,4,6-trifluoro-phe-
nyl)-pyridazine (18, 0.43 g, 1.1 mmol, 93%) as colourloss crystals.
1H NMR (CDCl3): d = 4.13 (s, 3H), 6.59–6.70 (m, 2H), 7.08 (d, 2H),
7.29 (d, 2H). MS (ESI): m/z = 385 (M), 387 (M+2)
4.1.7. 3-(4-Chloro-phenyl)-4-(2,4,6-trifluoro-phenyl)-furan-2,5-
dione (15)
4.2. Biochemistry
Potassium tert-butoxide (53 g, 0.47 mol) was added in portions
to a solution of 4-chloro-phenylglyoxylic acid (14, 86 g, 0.47 mol)
in 700 ml of methanol at room temperature. The mixture was stir-
red for 1 h at this temperature, then the white solid, which precip-
itated, was filtered, washed with cold methanol and dried in vacuo.
This potassium salt was taken up in 800 ml of acetic anhydride and
then 2,4,6-trifluorophenylacetic acid (73 g, 0.38 mol) was added.
The reaction mixture was heated first for 1 h to 80 °C, then for
1 h to 90 °C and finally for 1 h to 100 °C. Subsequently the mixture
was cooled to room temperature and the solvent was removed in
vacuo to obtain 3-(4-chloro-phenyl)-4-(2,4,6-trifluoro-phenyl)-
furan-2,5-dione (15, 148 g, 0.44 mol, 93%), which was directly
used in the next step without further purification. 1H NMR (CDCl3):
d = 6.76–6.83 (m, 2H), 7.30 (d, 2H), 7.82 (d, 2H). MS (ESI): m/z = 339
(M+1).
4.2.1. Compounds testing on pure porcine tubulin
The HTS-tubulin polymerisation assay kit (Cytoskeleton Inc.,
Denver, USA) has been used following the manufacturer instruc-
tion. The standard polymerisation reaction contains 100 ll volume
of 4 mg/ml tubulin in 80 mM PIPES pH 6.9, 0.5 mM EGTA, 2 mM
MgCl2 and 1 mM GTP. The polymerisation was started by incuba-
tion at 37 °C and followed by absorption readings at 340 nm (Spec-
tramax). Paclitaxel and DMSO were used as positive and negative
controls, respectively. 3-Chloro-5-(5-chloro-thiophen-2-yl)-6-
methyl-4-(2,4,6-trifluoro-phenyl)-pyridazine (10) was added in
different wells of a 96-well plate at the beginning of the reaction
at different concentrations (20, 2.2, 0.24 ppm) in a DMSO solution
(0.2 mM).
4.3. Biology
4.1.8. 4-(4-Chloro-phenyl)-5-(2,4,6-trifluoro-phenyl)-1,2-
dihydro-pyridazine-3,6-dione (16)
All tested compounds had a purity of at least 95%, the purifica-
tion has been either performed via chromatography (see Sections
4.1.5, 4.1.9 and 4.1.10) or by crystalisation.
120 g of a 2:1 mixture of hydrazine hydrate and water was
added dropwise to a mixture of 3-(4-chloro-phenyl)-4-(2,4,6-tri-
fluoro-phenyl)-furan-2,5-dione (15, 80 g, 0.24 mol) in 270 ml of
acetic acid. Sodium acetate anhydrous (22 g, 0.27 mol), was added
and the reaction mixture was heated to reflux for 2 h. Subsequently
the mixture was cooled, diluted with water and extracted with
ethyl acetate. The organic layer was washed with brine, dried over
sodium sulfate and evaporated under reduced pressure. The
residue was purified by chromatography on silica gel, using ethyl
acetate/heptane 1:3 as eluent, delivering 4-(4-chloro-phenyl)-5-
(2,4,6-trifluoro-phenyl)-1,2-dihydropyridazine-3,6-dione (16, 47 g,
0.13 mol, 57%) as colourless crystals. Mp 159–164 °C. 1H NMR
(CDCl3): d = 6.61 (t, 2H), 7.13 (d, 2H), 7.27 (d, 2H), 11.97 (br s,
1H), 13.83 (br s, 1H). MS (ESI): m/z = 353 (M), 355 (M+2).
4.3.1. Botryotinia fuckeliana (Botrytis cinerea)/tomato (action
against grey mould on tomato)
Four-week old tomato plants cv. Roter Gnom were treated in a
spray chamber with the formulated test compound diluted in
water. The test plants were inoculated by spraying them with a
spore suspension two days after application. The inoculated test
plants were incubated at 20 °C and 95% rh in a greenhouse and
the percentage leaf area covered by disease was assessed when
an appropriate level of disease appeared on untreated check plants
(5–6 days after application).